[Lymphedema: which drug therapy?].
Identifieur interne : 000A64 ( Ncbi/Merge ); précédent : 000A63; suivant : 000A65[Lymphedema: which drug therapy?].
Auteurs : V. Boursier [France]Source :
- La Revue de medecine interne [ 0248-8663 ] ; 2002.
Descripteurs français
- KwdFr :
- MESH :
- traitement médicamenteux : Lymphoedème.
- usage thérapeutique : Anticoagulants, Coumarines, Diurétiques, Flavonoïdes.
- Femelle, Humains, Tumeurs du sein.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Anticoagulants, Coumarins, Diuretics, Flavonoids.
- complications : Breast Neoplasms.
- drug therapy : Lymphedema.
- Female, Humans.
Abstract
Treatment of primary or secondary lymphedema includes essentially complex decongestive physiotherapy. For many years now, drugs active in reducing volume of lymphedema are prospected. But few studies are available. Only few drugs have been tested. Diuretics have been the first to be used with short and brief efficacy. Benzopyrones were the most tested product with encouraging but conflicting results. New treatments are proposed without randomized controlled studies. Prevention of lymphedema remains essential in particular after treatment of breast cancer.
PubMed: 12162207
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 004507
- to stream PubMed, to step Curation: 004507
- to stream PubMed, to step Checkpoint: 004507
Links to Exploration step
pubmed:12162207Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Lymphedema: which drug therapy?].</title>
<author><name sortKey="Boursier, V" sort="Boursier, V" uniqKey="Boursier V" first="V" last="Boursier">V. Boursier</name>
<affiliation wicri:level="3"><nlm:affiliation>Unité de lymphologie, hôpital Cognacq-Jay, site Broussais, 102, rue Didot, 75014 Paris, France. virginie.boursier@voila.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité de lymphologie, hôpital Cognacq-Jay, site Broussais, 102, rue Didot, 75014 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:12162207</idno>
<idno type="pmid">12162207</idno>
<idno type="wicri:Area/PubMed/Corpus">004507</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004507</idno>
<idno type="wicri:Area/PubMed/Curation">004507</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004507</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004507</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004507</idno>
<idno type="wicri:Area/Ncbi/Merge">000A64</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Lymphedema: which drug therapy?].</title>
<author><name sortKey="Boursier, V" sort="Boursier, V" uniqKey="Boursier V" first="V" last="Boursier">V. Boursier</name>
<affiliation wicri:level="3"><nlm:affiliation>Unité de lymphologie, hôpital Cognacq-Jay, site Broussais, 102, rue Didot, 75014 Paris, France. virginie.boursier@voila.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité de lymphologie, hôpital Cognacq-Jay, site Broussais, 102, rue Didot, 75014 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">La Revue de medecine interne</title>
<idno type="ISSN">0248-8663</idno>
<imprint><date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anticoagulants (therapeutic use)</term>
<term>Breast Neoplasms (complications)</term>
<term>Coumarins (therapeutic use)</term>
<term>Diuretics (therapeutic use)</term>
<term>Female</term>
<term>Flavonoids (therapeutic use)</term>
<term>Humans</term>
<term>Lymphedema (drug therapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Anticoagulants (usage thérapeutique)</term>
<term>Coumarines (usage thérapeutique)</term>
<term>Diurétiques (usage thérapeutique)</term>
<term>Femelle</term>
<term>Flavonoïdes (usage thérapeutique)</term>
<term>Humains</term>
<term>Lymphoedème (traitement médicamenteux)</term>
<term>Tumeurs du sein ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anticoagulants</term>
<term>Coumarins</term>
<term>Diuretics</term>
<term>Flavonoids</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticoagulants</term>
<term>Coumarines</term>
<term>Diurétiques</term>
<term>Flavonoïdes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Femelle</term>
<term>Humains</term>
<term>Tumeurs du sein</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Treatment of primary or secondary lymphedema includes essentially complex decongestive physiotherapy. For many years now, drugs active in reducing volume of lymphedema are prospected. But few studies are available. Only few drugs have been tested. Diuretics have been the first to be used with short and brief efficacy. Benzopyrones were the most tested product with encouraging but conflicting results. New treatments are proposed without randomized controlled studies. Prevention of lymphedema remains essential in particular after treatment of breast cancer.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12162207</PMID>
<DateCreated><Year>2002</Year>
<Month>08</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted><Year>2002</Year>
<Month>09</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>10</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0248-8663</ISSN>
<JournalIssue CitedMedium="Print"><Volume>23 Suppl 3</Volume>
<PubDate><Year>2002</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>La Revue de medecine interne</Title>
<ISOAbbreviation>Rev Med Interne</ISOAbbreviation>
</Journal>
<ArticleTitle>[Lymphedema: which drug therapy?].</ArticleTitle>
<Pagination><MedlinePgn>421s-425s</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Treatment of primary or secondary lymphedema includes essentially complex decongestive physiotherapy. For many years now, drugs active in reducing volume of lymphedema are prospected. But few studies are available. Only few drugs have been tested. Diuretics have been the first to be used with short and brief efficacy. Benzopyrones were the most tested product with encouraging but conflicting results. New treatments are proposed without randomized controlled studies. Prevention of lymphedema remains essential in particular after treatment of breast cancer.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boursier</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Unité de lymphologie, hôpital Cognacq-Jay, site Broussais, 102, rue Didot, 75014 Paris, France. virginie.boursier@voila.fr</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>fre</Language>
<PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Lymphoedème: quel traitement médicamenteux?</VernacularTitle>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Rev Med Interne</MedlineTA>
<NlmUniqueID>8101383</NlmUniqueID>
<ISSNLinking>0248-8663</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003374">Coumarins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004232">Diuretics</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005419">Flavonoids</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>A4VZ22K1WT</RegistryNumber>
<NameOfSubstance UI="C030123">coumarin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003374" MajorTopicYN="N">Coumarins</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004232" MajorTopicYN="N">Diuretics</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005419" MajorTopicYN="N">Flavonoids</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>20</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year>
<Month>8</Month>
<Day>7</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2002</Year>
<Month>9</Month>
<Day>28</Day>
<Hour>4</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2002</Year>
<Month>8</Month>
<Day>7</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">12162207</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
<region><li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
</settlement>
</list>
<tree><country name="France"><region name="Île-de-France"><name sortKey="Boursier, V" sort="Boursier, V" uniqKey="Boursier V" first="V" last="Boursier">V. Boursier</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A64 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000A64 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:12162207 |texte= [Lymphedema: which drug therapy?]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:12162207" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |